rs190967484

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_001365276.2(TNXB):​c.4848G>A​(p.Gly1616Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0104 in 1,613,086 control chromosomes in the GnomAD database, including 132 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 16 hom., cov: 32)
Exomes 𝑓: 0.010 ( 116 hom. )

Consequence

TNXB
NM_001365276.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.688

Publications

1 publications found
Variant links:
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome due to tenascin-X deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Illumina, Genomics England PanelApp, PanelApp Australia
  • familial vesicoureteral reflux
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • vesicoureteral reflux 8
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 6-32072132-C-T is Benign according to our data. Variant chr6-32072132-C-T is described in ClinVar as Benign. ClinVar VariationId is 261139.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.688 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0101 (1534/152282) while in subpopulation NFE AF = 0.0127 (862/68012). AF 95% confidence interval is 0.012. There are 16 homozygotes in GnomAd4. There are 823 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 16 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001365276.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TNXB
NM_001365276.2
MANE Select
c.4848G>Ap.Gly1616Gly
synonymous
Exon 13 of 44NP_001352205.1P22105-3
TNXB
NM_001428335.1
c.5589G>Ap.Gly1863Gly
synonymous
Exon 14 of 45NP_001415264.1A0A3B3ISX9
TNXB
NM_019105.8
c.4848G>Ap.Gly1616Gly
synonymous
Exon 13 of 44NP_061978.6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TNXB
ENST00000644971.2
MANE Select
c.4848G>Ap.Gly1616Gly
synonymous
Exon 13 of 44ENSP00000496448.1P22105-3
TNXB
ENST00000647633.1
c.5589G>Ap.Gly1863Gly
synonymous
Exon 14 of 45ENSP00000497649.1A0A3B3ISX9
TNXB
ENST00000375244.7
TSL:5
c.4848G>Ap.Gly1616Gly
synonymous
Exon 13 of 44ENSP00000364393.3P22105-3

Frequencies

GnomAD3 genomes
AF:
0.0101
AC:
1534
AN:
152164
Hom.:
16
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00140
Gnomad AMI
AF:
0.0581
Gnomad AMR
AF:
0.00524
Gnomad ASJ
AF:
0.0343
Gnomad EAS
AF:
0.000963
Gnomad SAS
AF:
0.00539
Gnomad FIN
AF:
0.0293
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0127
Gnomad OTH
AF:
0.00812
GnomAD2 exomes
AF:
0.0101
AC:
2514
AN:
247782
AF XY:
0.0105
show subpopulations
Gnomad AFR exome
AF:
0.00164
Gnomad AMR exome
AF:
0.00396
Gnomad ASJ exome
AF:
0.0363
Gnomad EAS exome
AF:
0.000390
Gnomad FIN exome
AF:
0.0260
Gnomad NFE exome
AF:
0.0107
Gnomad OTH exome
AF:
0.0110
GnomAD4 exome
AF:
0.0105
AC:
15295
AN:
1460804
Hom.:
116
Cov.:
31
AF XY:
0.0106
AC XY:
7684
AN XY:
726640
show subpopulations
African (AFR)
AF:
0.00191
AC:
64
AN:
33470
American (AMR)
AF:
0.00424
AC:
189
AN:
44628
Ashkenazi Jewish (ASJ)
AF:
0.0347
AC:
907
AN:
26116
East Asian (EAS)
AF:
0.000227
AC:
9
AN:
39700
South Asian (SAS)
AF:
0.00501
AC:
431
AN:
86102
European-Finnish (FIN)
AF:
0.0255
AC:
1355
AN:
53172
Middle Eastern (MID)
AF:
0.00555
AC:
32
AN:
5768
European-Non Finnish (NFE)
AF:
0.0106
AC:
11775
AN:
1111502
Other (OTH)
AF:
0.00883
AC:
533
AN:
60346
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
857
1714
2571
3428
4285
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
422
844
1266
1688
2110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0101
AC:
1534
AN:
152282
Hom.:
16
Cov.:
32
AF XY:
0.0111
AC XY:
823
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.00140
AC:
58
AN:
41562
American (AMR)
AF:
0.00523
AC:
80
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0343
AC:
119
AN:
3472
East Asian (EAS)
AF:
0.000965
AC:
5
AN:
5182
South Asian (SAS)
AF:
0.00540
AC:
26
AN:
4818
European-Finnish (FIN)
AF:
0.0293
AC:
311
AN:
10616
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0127
AC:
862
AN:
68012
Other (OTH)
AF:
0.00803
AC:
17
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
76
152
228
304
380
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0144
Hom.:
8
Bravo
AF:
0.00755
Asia WGS
AF:
0.00491
AC:
17
AN:
3478
EpiCase
AF:
0.0128
EpiControl
AF:
0.00950

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Ehlers-Danlos syndrome (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.42
CADD
Benign
12
DANN
Benign
0.67
PhyloP100
-0.69
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.15
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs190967484; hg19: chr6-32039909; COSMIC: COSV64490030; API